Home › Crohn's Disease › Missouri › St. Louis

Pag-aaral pangklinika para sa Crohn's Disease sa St. Louis, MO

19 pag-aaral para sa Crohn's Disease ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng St. Louis (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Nagre-recruitPhase 2

Specialists In Gastroenterology /ID# 283939, St Louis

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07697456

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Nagre-recruitPhase 1

Washington University School of Medicine, St Louis
Siteman Cancer Center-South County, St Louis
Siteman Cancer Center at Christian Hospital, St Louis
at 1 pa

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT03816345

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Nagre-recruitPhase 3

Washington University School of Medicine ( Site 5058), St Louis

Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06430801

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Nagre-recruitPhase 4

SSM Health Medical Group, Bridgeton · 15 mi ang layo

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06581328

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Nagre-recruitPhase 2

Washington University /ID# 266938, St Louis

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06548542

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Nagre-recruitPhase 3

Washington University School of Medicine, St Louis

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Nagre-recruitPhase 3

Washington University School of Medicine-Site Number: 8400075, St Louis
Gateway Gastroenterology-Site Number: 8400097, St Louis

Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Nagre-recruitPhase 3

Gateway Gastroenterology-Site Number: 8400097, St Louis

Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07184944

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Nagre-recruitPhase 3

Washington University School of Medicine, St Louis

Edad 2 hanggang 19 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT04844606

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

Nagre-recruitPhase 2

KAD Clinical Research, St Louis

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07483099

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Nagre-recruitPhase 2

SSM Health DePaul Hospital- St. Louis, Bridgeton · 15 mi ang layo

Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06226883

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

Nagre-recruitPhase 2

KAD Clinical Research, St Louis

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07483073

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Nagre-recruitPhase 4

Washington University School of Medicine, St Louis

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06045754

DB-3Q for the Treatment of Medically Refractory Crohn's Disease

Nagre-recruitPhase 2

Washington University, St. Louis, St Louis

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT07625293

Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease

Nagre-recruitPhase 2

Washington University School of Medicine, St Louis

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Hun 5, 2026 · NCT06976853

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

Nagre-recruitPhase 2

Investigational Site Number: 8400013, St Louis

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Mar 27, 2026 · NCT06958536

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Nagre-recruitPhase 2

Mirador Therapeutics Selected Site, Bridgeton · 15 mi ang layo

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Mar 12, 2026 · NCT07113522

Treatment of Moderate to Severe Refractory Crohn's Disease

Nagre-recruitPhase 1/2

Washington University in St. Louis, St Louis

Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Dis 10, 2025 · NCT06721962

Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy

Nagre-recruitObservasyonal na pag-aaral

Washington University in St Louis School of Medicine, St Louis

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2025 · NCT06670638

Pag-aaral para sa Crohn's Disease sa ibang lungsod

Iba pang pag-aaral sa St. Louis

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.